Results 61 to 70 of about 72,146 (78)

Targeted Therapy in Acute Myeloid Leukemia: Current Approaches and Novel Directions. [PDF]

J Pers Med
Ko KH, Gelfer R, Wheat JC, Cai SF.
europepmc   +1 more source

Ontogeny Dictates Oncogenic Potential, Lineage Hierarchy, and Therapy Response in Pediatric Leukemia. [PDF]

Cancer Discov
Wang K, Saniei S, Poddar N, Martinez IG, Chao C, Autar S, Fiore P, Carcamo S, Sreenath M, Peplinski JH, Ries RE, Mei AH, Rahman NA, Mekerishvili L, Quijada-Álamo M, Freed G, Zhang M, Lachman K, Diaz Z, Gonzalez MM, Zhang J, Pham G, Filipescu D, Berisa M, Balestra T, Wheeler N, Reisz JA, D'Alessandro A, Puleston DJ, Bernstein E, Chipuk JE, Wunderlich M, Tasian SK, Marcellino BK, Glass IA, BDRL, Sturgeon CM, Landau DA, Chen Z, Papapetrou EP, Izzo F, Meshinchi S, Hasson D, Wagenblast E, BDRL.   +44 more
europepmc   +1 more source

Loss of FBXO11 establishes a stem cell program in acute myeloid leukemia by dysregulating LONP1. [PDF]

J Clin Invest
Kincross H, Mo YA, Wang X, Chang L, Duns G, Mey F, Jiang J, Zhu Z, Isak N, Kwan H, Lau TT, Docking TR, Garg P, Tran J, Colborne S, Cheng SG, Huang S, Gharaee N, Willie E, Parker JD, Bridgers J, Wood D, Klein Geltink RI, Morin GB, Karsan A.   +24 more
europepmc   +1 more source

Myeloid sarcoma transformed from myeloproliferative neoplasm: A case report and review of literature. [PDF]

World J Clin Oncol
Zhong SH, Lou J, Zhao AQ, Jin XL, Wei SM, Liang Y.   +5 more
europepmc   +1 more source

Circ-RERE promotes autophagy and immune escape in acute myeloid leukemia involving the miR-128-3p/ZEB1/PD-L1 axis. [PDF]

Clinics (Sao Paulo)
Shi X, Wang T, Sha K, Li S, Pei R, Lu Y.
europepmc   +1 more source

Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation.

Blood
Ling T, O'Brien C, St-Germain JR, Rondeau V, Shi M, Berman JM, Cepa A, Saez Raez P, Wunderlich M, Carter KM, Stillwell C, Sexton C, Culp-Hill R, Reisz JA, Adeel SA, Zeng AGX, Bansal S, Tsao E, Chen HT, Dick JE, Minden MD, Arruda A, Amaya ML, Tikhonova AN, Hope KJ, D'Alessandro A, Raught B, Jones CL.   +27 more
europepmc   +1 more source

Targeting TLK2 with antisense oligonucleotides as a new strategy in acute myeloid leukemia. [PDF]

Front Oncol
Lin HY, Khou S, Lind E, de Oliveira Rebola KG, Dean A, Zhang H, Tolentino A, Maazi H, Revenko A, Agarwal A.   +9 more
europepmc   +1 more source

Next-generation CAR-T therapy for acute myeloid leukemia: bridging innovation with clinical translation. [PDF]

Ann Hematol
Zhao X, Ming X, Wu J, Zhu X, Xiao Y.
europepmc   +1 more source

IL-1 signaling and inflammasomes in acute myeloid leukemia: mechanisms and therapeutic opportunities. [PDF]

Cell Mol Life Sci
Mortellaro A, Mastaglio S, Muzio M.
europepmc   +1 more source

Aggressive Disease and Poor Clinical Outcome in CEBPα-Mutated Acute Myeloid Leukemia Patient. [PDF]

Clin Case Rep
Alshammari AA, AlSabbagh MO, Alshehri HM, AlSwayyed AF, Alseraye FM, Peer-Zada AA.   +5 more
europepmc   +1 more source